Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo

Overview of attention for article published in BMC Cancer, September 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

patent: 5 patents

Readers on

mendeley: 43 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

H-1 PV EXPRESSING RNAi EFFECTORS

Application WO-2022219065-A1

World Intellectual Property Organisation (WIPO)

20 Oct 2022

H-1 PV EXPRESSING RNAI EFFECTORS

Application EP-4074835-A1

European Patent Office

19 Oct 2022

H-1 PV EXPRESSING RNAI EFFECTORS TARGETING CDK9

Application WO-2018096148-A1

World Intellectual Property Organisation (WIPO)

31 May 2018

H-1 PV EXPRESSING RNAI EFFECTORS TARGETING CDK9

Application EP-3327124-A1

European Patent Office

30 May 2018

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.